Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ribosomal DNA loci in Plasmodium falciparum accumulate mutations independently.

Journal of molecular biology·1995
Same author

Binding of phenylarsenoxide to Arg-tRNA protein transferase is independent of vicinal thiols.

Biochemistry·1995
Same author

The oncogene qin codes for a transcriptional repressor.

Cancer research·1995
Same author

Non-receptor cytosolic protein tyrosine kinases from various rat tissues.

Biochimica et biophysica acta·1995
Same author

Mutagenesis in the C-terminal region of human interleukin 5 reveals a central patch for receptor alpha chain recognition.

Proceedings of the National Academy of Sciences of the United States of America·1995
Same author

Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain.

The Journal of biological chemistry·1995

Related Experiment Video

Updated: Jun 27, 2026

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain
06:12

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain

Published on: January 27, 2022

Limbal stem cell transplantation: new progresses and challenges.

L Liang1, H Sheha, J Li

  • 1Department of Tissue Tech., Ocular Surface Center, Ocular Surface Research and Education Foundation, Miami, FL, USA.

Eye (London, England)
|December 23, 2008
PubMed
Summary

New strategies using amniotic membrane transplantation (AMT) can prevent and treat limbal stem cell deficiency (LSCD). AMT preserves stem cells in acute stages and aids reconstruction in advanced cases, improving vision and ocular surface health.

More Related Videos

A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse
04:55

A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse

Published on: November 17, 2016

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Related Experiment Videos

Last Updated: Jun 27, 2026

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain
06:12

Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain

Published on: January 27, 2022

A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse
04:55

A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse

Published on: November 17, 2016

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Corneal Surgery

Background:

  • Limbal stem cell deficiency (LSCD) causes severe vision loss and photophobia, often uncorrectable by conventional penetrating keratoplasty.
  • Current treatments for LSCD are limited, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To review and synthesize current literature on novel strategies for treating LSCD.
  • To explore the efficacy of amniotic membrane transplantation (AMT) in preventing and managing LSCD.
  • To discuss future challenges in ocular surface reconstruction and squamous metaplasia.

Main Methods:

  • Literature review of studies on LSCD treatment.
  • Analysis of amniotic membrane transplantation (AMT) applications in various LSCD stages.
  • Evaluation of adjunctive therapies and surgical techniques for LSCD management.

Main Results:

  • Early AMT application in acute chemical burns and Stevens-Johnson syndrome prevents LSCD by preserving limbal stem cells.
  • AMT as a graft, with or without sutures and fibrin glue, facilitates stem cell expansion in partial to total LSCD.
  • AMT aids corneal surface reconstruction, reducing autograft size and enhancing allograft success for total LSCD.

Conclusions:

  • Amniotic membrane transplantation (AMT) offers a versatile strategy for preventing and treating limbal stem cell deficiency (LSCD).
  • Successful management of bilateral total LSCD requires a multi-faceted approach including immunosuppression and ocular surface optimization.
  • Further research is needed to address challenges in squamous metaplasia and improve long-term ocular surface health.